The sale had net proceeds of $132 million, after fees and discounts, which Incyte plans to use for research and development and general expenses.
The underwriters bought 2.7 million shares. Goldman Sachs was the book-running manager. Morgan Stanley & Co. and JPMorgan Securities Inc. were co-managers.
Incyte is based in Wilmington, Del. Its shares fell 1 cents to $6.75 on Wednesday.
A service of YellowBrix, Inc.
